{"title":"How to detect SARS-CoV-2: A brief review about molecular diagnosis techniques","authors":"A. Carhan, Ender Şimşek, Özen Özensoy Güler","doi":"10.5505/turkhijyen.2022.87533","DOIUrl":null,"url":null,"abstract":"A new type of coronavirus (SARS-CoV-2) was detected in patients with acute respiratory disease in 2019. SARS-CoV-2 is a virus that can cause fever, dry cough, shortness of breath, anorexia, fatigue and sore throat, which can be transmitted through respiration and has started to spread around the world and has become a global problem. The disease caused by SARS-COV-2 has been named Coronavirus Disease 2019 (Covid-19) by the World Health Organization (WHO). According to the WHO, Covid-19 is a pandemic and it is stated that humanity has not experienced such an epidemic in the last hundred years. The coronavirus originated from bats and was transmitted to human through unknown animals in Wuhan province of China in December 2019. On January 2021, 96.658.420 confirmed cases and 2.092.062 deaths have occurred in the world. There is a growing need in the detection of SARS-CoV-2. A number of problems and difficulties are observed in the diagnosis and treatment of Covid-19. Chest tomography and molecular tests are used to detect SARS-CoV-2. The molecular techniques used are PCR-based and non-PCR-based methods. Usually detection of SARS-CoV-2 is based on PCR, but isothermal nucleic acid amplification tests have also been promising alternatives. Currently, qRT-PCR is a golden assay and it is widely used although many alternative assays have been developed for recent years. The current testing capacity and availability can not meet the unprecedented global demands for rapid, reliable and widely accessible molecular diagnosis. In addition, there is a need for a comprehensive strategy compare the molecular techniques used in the field. Since in this review we aim to give a summary of molecular diagnosis techniques to detect Covid 19 © 2022, Turk Hijyen ve Deneysel Biyoloji Dergisi. All Rights Reserved.","PeriodicalId":35553,"journal":{"name":"Turk hijiyen ve deneysel biyoloji dergisi. Turkish bulletin of hygiene and experimental biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turk hijiyen ve deneysel biyoloji dergisi. Turkish bulletin of hygiene and experimental biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/turkhijyen.2022.87533","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
如何检测SARS-CoV-2:分子诊断技术综述
2019年在急性呼吸道疾病患者中发现了一种新型冠状病毒(SARS-CoV-2)。SARS-CoV-2是一种可引起发烧、干咳、呼吸短促、厌食、疲劳和喉咙痛的病毒,可通过呼吸传播,已开始在世界范围内传播,已成为全球性问题。由SARS-COV-2引起的疾病被世界卫生组织命名为2019冠状病毒病(Covid-19)。根据世界卫生组织的说法,新冠肺炎是一场大流行,据说人类在过去的一百年里从未经历过这样的流行病。冠状病毒起源于蝙蝠,于2019年12月在中国武汉市通过未知动物传播给人类。截至2021年1月,全球确诊病例为96.658.420例,死亡病例为2.092.062例。检测SARS-CoV-2的需求越来越大。新冠肺炎诊疗中存在一些问题和困难。胸部断层扫描和分子检测用于检测SARS-CoV-2。所使用的分子技术有基于聚合酶链反应和非基于聚合酶链反应的方法。通常检测SARS-CoV-2是基于PCR的,但等温核酸扩增检测也是有希望的替代方法。目前,qRT-PCR是一种黄金检测方法,尽管近年来开发了许多替代检测方法,但它被广泛使用。目前的检测能力和可用性无法满足全球对快速、可靠和广泛可及的分子诊断的空前需求。此外,还需要一个综合的策略来比较该领域使用的分子技术。在这篇综述中,我们的目的是总结检测Covid - 19的分子诊断技术©2022,Turk Hijyen ve Deneysel Biyoloji Dergisi。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。